Update on the role of the AT2 receptor

被引:95
|
作者
Carey, RM [1 ]
机构
[1] Univ Virginia, Hlth Syst, Div Endocrinol & Metab, Dept Med, Charlottesville, VA 22908 USA
来源
关键词
angiotensin; angiotensin receptors; bradykin; kidney; nitric oxide; sodium excretion; vasodilation;
D O I
10.1097/00041552-200501000-00011
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose of review The renin-angiotensin system is a coordinated hormonal cascade important to the regulation of the renal sodium excretion and blood pressure. The major effector peptide, angiotensin II, binds two major receptors, AT(1) and AT(2). While the majority of angiotensin II actions are mediated via the AT(1) receptor, evidence has accumulated that the AT(2) receptor opposes the AT(1) receptor, especially by inducing vasodilation instead of vasoconstriction. Recent findings During the past year, the evidence for an AT(2) receptor microvascular dilator action has been presented that is mediated by nitric oxide (NO) generation in a bradykinin-dependent or independent manner. Although the AT(2) receptor is expressed in renal proximal and distal tubules and vasculature, and AT(2) receptor stimulation induces a bradykinin/NO pathway within the kidney, little information is available concerning AT(2) receptor regulation of renal function and sodium excretion. From studies reported this year, the AT(2) receptor appears to be protective against ischemic renal injury. Summary The AT(2) receptor represents a potentially important area of investigation with therapeutic applications in the future.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 50 条
  • [41] AT2 Receptor Activities and Pathophysiological Implications
    Matavelli, Luis C.
    Siragy, Helmy M.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2015, 65 (03) : 226 - 232
  • [42] AT2 receptor agonists: hypertension and beyond
    Steckelings, Ulrike M.
    Paulis, Ludovit
    Namsolleck, Pawel
    Unger, Thomas
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2012, 21 (02): : 142 - 146
  • [43] Angiotensin Peptides as AT2 Receptor Agonists
    Hallberg, Mathias
    Savmarker, Jonas
    Hallberg, Anders
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2017, 18 (08) : 809 - 818
  • [44] The AT2 receptor - A matter of love and hate
    Steckelings, UM
    Kaschina, E
    Unger, T
    PEPTIDES, 2005, 26 (08) : 1401 - 1409
  • [45] Hypovolaemia-induced vasodilatation during angiotensin AT1 receptor blockade:: role of the AT2 receptor
    Ryckwaert, F
    Colson, PH
    PHARMACOLOGICAL RESEARCH, 2005, 51 (01) : 37 - 40
  • [46] Saralasin and Sarile Are AT2 Receptor Agonists
    Guimond, Marie-Odile
    Hallberg, Mathias
    Gallo-Payet, Nicole
    Wallinder, Charlotta
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (10): : 1129 - 1132
  • [47] The role of the angiotensin-II receptor 2 (AT2) in bleomycin-induced pulmonary fibrosis
    Wilhelm, A
    Königshoff, M
    Seeger, W
    Rose, F
    MEDIZINISCHE KLINIK, 2006, 101 (04) : A70 - A70
  • [48] AT2 Receptor-interacting Protein Enhances Protective Effect of AT2 Receptor Stimulation in Ischemic Brain Damage
    Iwanami, Jun
    Mogi, Masaki
    Wang, Xiao-Li
    Tsukuda, Kana
    Higaki, Akinori
    Kawakami, Moe
    Kukida, Masanori
    Nakaoka, Hirotomo
    Yamauchi, Toshifumi
    Bai, Hui-Yu
    Shan, Bao-Shuai
    Min, Li-Juan
    Horiuchi, Masatsugu
    STROKE, 2018, 49
  • [49] Role of the third intracellular loop of the Angiotensin II receptor subtype AT2 in ligand-receptor interaction
    Dittus, J
    Cooper, S
    Obermeir, G
    Pulakat, L
    FEBS LETTERS, 1999, 445 (01) : 23 - 26
  • [50] The signalling of AT2 and the influence on the collagen metabolism of AT2 receptor in adult rat cardiac fibroblasts
    Jiang, Xiao-Ying
    Gao, Guang-Dao
    Du, Xiao-Jun
    Zhou, Juan
    Wang, Xin-Feng
    Lin, Yuan-Xi
    ACTA CARDIOLOGICA, 2007, 62 (05) : 429 - 438